Background: Allergic rhinitis (AR) has been shown to impair social life and psychological functioning. The objective of our study was to explore the relationships between moderate-to-severe persistent AR and personality traits in non-psychiatric female outpatients. Methods: Female subjects were assigned to the allergic (n = 52, 24 singletons and 28 non-singletons) or non-allergic group (n = 28, 11 singletons and 17 non-singletons) on the basis of skin prick tests (SPT) and allergic symptoms. Individuals in this study were only allergic to Dermatophagoides pteronyssinus and/or D. farinae. The psychological aspects of the female subjects were assessed by using the Minnesota Multiphasic Personality Inventory (MMPI). Results: The allergic group scored significantly higher than the non-allergic group on 6 clinical scales [hypochondriasis (Hs), depression (D), hysteria (Hy), psychasthenia (Pt), schizophrenia (Sc), social introversion (Si)] and 1 validity scale [infrequency (F)]. Analysis of female singleton outpatient MMPI profiles showed that allergic subjects scored significantly higher on D, Hy, masculinity/femininity (Mf), Pt, and F. In addition, the grade of skin index (resulting from an SPT) was positively correlated with T-scores on the Hs, Hy, Pt, and Sc scales. Conclusion: Women with moderate-to-severe persistent AR, especially singleton patients, show poorer psychological functioning, indicating the close relationship between moderate-to-severe persistent AR and psychological functioning.

Keywords:
Allergic rhinitis, Personality, Minnesota Muliphasic Personality Inventory
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.